Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1T 10.42B 9.16B 8.64B 7.88B 14.74B 14.85B 104B 40.17B 509B 39.11B 38.26B 1,656B P/E 2027 *
26.8x
P/E 2028 * 20.7x
Enterprise Value 968B 10.09B 8.87B 8.36B 7.63B 14.27B 14.38B 100B 38.9B 493B 37.87B 37.05B 1,604B EV / Sales 2027 *
2.75x
EV / Sales 2028 * 2.41x
Free-Float
69.71%
Yield 2027 *
0.63%
Yield 2028 * 0.7%
1 day+0.37%
1 week+0.90%
Current month+1.40%
1 month+0.65%
3 months-16.10%
6 months-8.55%
Current year-12.39%
1 week 12.25
Extreme 12.25
12.72
1 month 11.51
Extreme 11.51
12.72
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+0.90% - - 10.42B
+0.33%+2.56%+59.32%+114.68% 1,053B
+0.14%+0.17%+53.19%+68.65% 652B
+0.08%+0.42%+20.51%+73.58% 468B
-0.40%+1.35%+41.80%+44.90% 351B
+0.79%+4.00%+22.14%+29.41% 273B
+1.14%+0.02%+14.11%+11.68% 254B
+0.09%+6.91%+45.42%+51.68% 220B
+0.19%-0.80%+31.69%+99.56% 186B
+0.55%-9.73%-29.62%-60.11% 170B
Average +0.34%+0.30%+28.73%+48.22% 403.04B
Weighted average by Cap. +0.31%+1.00%+39.12%+67.93%

Financials

2027 *2028 *
Net sales 352B 3.67B 3.22B 3.04B 2.77B 5.19B 5.23B 36.47B 14.13B 179B 13.76B 13.46B 583B 393B 4.09B 3.6B 3.39B 3.1B 5.79B 5.83B 40.71B 15.78B 200B 15.36B 15.03B 650B
Net income 36.93B 385M 338M 319M 291M 544M 549M 3.83B 1.48B 18.8B 1.44B 1.41B 61.17B 48.82B 509M 447M 422M 385M 720M 725M 5.06B 1.96B 24.85B 1.91B 1.87B 80.86B
Net Debt -31.58B -329M -289M -273M -249M -465M -469M -3.27B -1.27B -16.07B -1.24B -1.21B -52.3B -51.62B -538M -473M -446M -407M -761M -767M -5.35B -2.07B -26.27B -2.02B -1.98B -85.49B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-09-24 US$12.30 -0.73% 3,036,577
26-09-23 US$12.39 -1.43% 2,485,104
26-09-22 US$12.57 +1.37% 3,093,864
26-09-21 US$12.40 +1.72% 2,386,184
26-09-18 US$12.19 0.00% 1,894,904
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
38
Last Close Price
1,200.40INR
Average target price
1,264.48INR
Spread / Average Target
+5.34%

Quarterly revenue - Rate of surprise